RBDCOV Talks

RBDCOV
  • 0,0 (0)
  • MEDICINA
  • SERIE COMPLETA
RBDCOV Talks

RBDCOV Talks is a ten-episode series where RBDCOV's leading scientists, researchers, medical professionals and community advocates will take us on a knowledge-packed journey to explore and discuss the world of vaccine clinical trials. In these episodes, we will understand how vaccine clinical trials work and talk through interesting topics such as inclusion criteria in a vaccine clinical trial, personalised vaccines and what exactly immunological memory is.

Episodios

  1. In 5 minutes, what is a recombinant protein vaccine?

    EPISODIO 1

    In 5 minutes, what is a recombinant protein vaccine?

    🧬Dive into the world of recombinant protein vaccines in just 10 minutes with Antonio Barreiro from HIPRA. Unveil the science behind this innovative approach to HIPRA’s vaccine development.

    11 min
  2. What’s Drug Safety? What is Drug Safety-level safety monitoring like in vaccine clinical trials?

    EPISODIO 2

    What’s Drug Safety? What is Drug Safety-level safety monitoring like in vaccine clinical trials?

    Discover the critical role of Drug Safety in vaccine trials with Helena Belinchon from ASPHALION. 🩺 How do experts ensure safety at every level? Join the safety journey now! 🌟💊

    9 min
  3. All about vaccine clinical trials: what are they and how do they work?

    EPISODIO 3

    All about vaccine clinical trials: what are they and how do they work?

    Explore the intricate world of vaccine clinical trials with Montse Barceló from VERISTAT. 🧪 What are they, and how do they shape the future of healthcare?

    11 min
  4. All about immunological memory: what is it, how is it obtained and what is the result?

    EPISODIO 4

    All about immunological memory: what is it, how is it obtained and what is the result?

    Unveil the vital role of immunological memory, the key to long-lasting, protective immunity with Pere Soler Palacin from Vall D'Hebron. Understand why vaccinations earn immense respect in the scientific community for bolstering our defenses against infectious diseases. 🌐💪

    6 min
  5. Why have paediatric and adolescent participants been included in this trial?

    EPISODIO 5

    Why have paediatric and adolescent participants been included in this trial?

    Explore the significance of including the youngest in vaccine trials with Pablo Rojo from PENTA. Join us as we discuss the impact on child health and the broader community. 🌍💉

    8 min
  6. Why should people living with HIV and other immunocompromising conditions be included in clinical trials similar to the RBDCOV trial?

    EPISODIO 6

    Why should people living with HIV and other immunocompromising conditions be included in clinical trials similar to the RBDCOV trial?

    Shed light on immunocompromised clinical trials inclusion. 🦠 Why involve those with HIV? Join our conversation with Juanfran C and Arda from EATG to understand better the significance for a more inclusive and effective future.

    8 min
  7. All about personalised vaccines: what are they and what is their future?

    EPISODIO 7

    All about personalised vaccines: what are they and what is their future?

    Delves into personalized vaccines. What makes them unique, and what does the future hold for customized immunization? Uncover its potential with Julia García-Prado from IrsiCaixa! 🚀🔍

    8 min
  8. Where are we with COVID-19 and what does the future hold?

    EPISODIO 8

    Where are we with COVID-19 and what does the future hold?

    Considering how changing the COVID situation is, let's understand where we are with COVID-19 and what the future holds with Dr. Mete Tam from METPHARM.

    12 min
  9. What will the direct contribution of RBDCOV be if both clinical trials are proven to be effective?

    EPISODIO 9

    What will the direct contribution of RBDCOV be if both clinical trials are proven to be effective?

    In this episode, we decode RBDCOV's direct contribution. What if both trials succeed? Let's understand the potential impact on global health with Dr. Antoni Castro from IDIBGI🌐💉

    6 min
  10. Trial results: what are they main findings and what’s next?

    EPISODIO 10

    Trial results: what are they main findings and what’s next?

    Why is data so crucial? Is it only significant for the scientific community? Let's address the importance of collaboration and data sharing for a health project with Laura Sesma from Zabala Innovation.

    8 min
  • 10 episodios

Información

RBDCOV Talks is a ten-episode series where RBDCOV's leading scientists, researchers, medical professionals and community advocates will take us on a knowledge-packed journey to explore and discuss the world of vaccine clinical trials. In these episodes, we will understand how vaccine clinical trials work and talk through interesting topics such as inclusion criteria in a vaccine clinical trial, personalised vaccines and what exactly immunological memory is.

Ficha técnica

  • Creado por
    RBDCOV
  • Episodios
    10
  • Clasificación
    Apto
  • Derechos de autor
    © RBDCOV
  • Sitio web del podcast
    RBDCOV Talks

Inicia sesión para escuchar episodios explícitos.

No te pierdas nada de este programa

Inicia sesión o regístrate para seguir programas, guardar episodios y conocer las últimas novedades.
Selecciona un país o una región

África, Oriente Medio e India

Asia-Pacífico

Europa

América Latina y el Caribe

Estados Unidos y Canadá